BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32219372)

  • 1. SLC6A14, a Na+/Cl--coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling.
    Sikder MOF; Sivaprakasam S; Brown TP; Thangaraju M; Bhutia YD; Ganapathy V
    Biochem J; 2020 Apr; 477(8):1409-1425. PubMed ID: 32219372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the amino acid transporter Slc6a14 suppresses tumour growth in spontaneous mouse models of breast cancer.
    Babu E; Bhutia YD; Ramachandran S; Gnanaprakasam JP; Prasad PD; Thangaraju M; Ganapathy V
    Biochem J; 2015 Jul; 469(1):17-23. PubMed ID: 26173258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer.
    Karunakaran S; Ramachandran S; Coothankandaswamy V; Elangovan S; Babu E; Periyasamy-Thandavan S; Gurav A; Gnanaprakasam JP; Singh N; Schoenlein PV; Prasad PD; Thangaraju M; Ganapathy V
    J Biol Chem; 2011 Sep; 286(36):31830-8. PubMed ID: 21771784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer.
    Lu Y; Jiang Z; Wang K; Yu S; Hao C; Ma Z; Fu X; Qin MQ; Xu Z; Fan L
    BMC Cancer; 2022 Jul; 22(1):833. PubMed ID: 35907820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy.
    Karunakaran S; Umapathy NS; Thangaraju M; Hatanaka T; Itagaki S; Munn DH; Prasad PD; Ganapathy V
    Biochem J; 2008 Sep; 414(3):343-55. PubMed ID: 18522536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer.
    Coothankandaswamy V; Cao S; Xu Y; Prasad PD; Singh PK; Reynolds CP; Yang S; Ogura J; Ganapathy V; Bhutia YD
    Br J Pharmacol; 2016 Dec; 173(23):3292-3306. PubMed ID: 27747870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreatic cancer cells.
    Cai A; Zheng H; Chen Z; Lin X; Li C; Yao Q; Bhutia YD; Ganapathy V; Chen R; Kou L
    Biochem J; 2020 May; 477(10):1923-1937. PubMed ID: 32379301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy.
    Bi Y; Jiang Y; Li X; Hou G; Li K
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):499-505. PubMed ID: 33225417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Suppressive Role of ARHGAP17 in Colon Cancer Through Wnt/β-Catenin Signaling.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Physiol Biochem; 2018; 46(5):2138-2148. PubMed ID: 29730655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanolic Extract of Traditional Chinese Medicine (TCM) Gamboge Inhibits Colon Cancer
    Wang W; Li Y; Chen Y; Chen H; Zhu P; Xu M; Wang H; Wu M; Yang Z; Hoffman RM; Gu Y
    Anticancer Res; 2018 Apr; 38(4):1917-1925. PubMed ID: 29599307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of Slc6a14 reduces cancer growth and metastatic spread and improves survival in KPC mouse model of spontaneous pancreatic cancer.
    Schniers BK; Wachtel MS; Sharma M; Korac K; Rajasekaran D; Yang S; Sniegowski T; Ganapathy V; Bhutia YD
    Biochem J; 2022 Mar; 479(5):719-730. PubMed ID: 35212370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis.
    Manigandan K; Manimaran D; Jayaraj RL; Elangovan N; Dhivya V; Kaphle A
    Biochimie; 2015 Dec; 119():103-12. PubMed ID: 26482805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JQ-1 Inhibits Colon Cancer Proliferation via Suppressing Wnt/β-Catenin Signaling and miR-21.
    Zhang Y; Tian S; Xiong J; Zhou Y; Song H; Liu C
    Chem Res Toxicol; 2018 May; 31(5):302-307. PubMed ID: 29600711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C ζ is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines.
    Luna-Ulloa LB; Hernández-Maqueda JG; Santoyo-Ramos P; Castañeda-Patlán MC; Robles-Flores M
    Carcinogenesis; 2011 Nov; 32(11):1615-24. PubMed ID: 21859831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning identifies SLC6A14 as a novel biomarker promoting the proliferation and metastasis of pancreatic cancer via Wnt/β-catenin signaling.
    Dang C; Bian Q; Wang F; Wang H; Liang Z
    Sci Rep; 2024 Jan; 14(1):2116. PubMed ID: 38267509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
    Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
    Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
    Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
    Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-590-3p promotes colon cancer cell proliferation via Wnt/β-catenin signaling pathway by inhibiting WIF1 and DKK1.
    Feng ZY; Xu XH; Cen DZ; Luo CY; Wu SB
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4844-4852. PubMed ID: 29164578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer.
    Reabroi S; Chairoungdua A; Saeeng R; Kasemsuk T; Saengsawang W; Zhu W; Piyachaturawat P
    Biomed Pharmacother; 2018 May; 101():414-421. PubMed ID: 29501763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.